A direct ELISA assay for quantitative determination of the inhibitory potency of small molecules inhibitors for JNK3

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 1, 2011, Pages 236-240

  Goettert, Márcia ^a   Luik, Sabine ^a   Graeser, Ralph ^b   Laufer, Stefan A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PROQINASE GMBH   (Germany)

Author keywords

Anti phospho ATF 2 (Thr 69 71) peroxidase antibody; ELISA; JNK3; MAPK; Small molecule inhibitors

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTOR 2 MONOCLONAL ANTIBODY; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; JANUS KINASE 3; JANUS KINASE 3 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IC 50; PERFORMANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RADIOASSAY; SENSITIVITY AND SPECIFICITY;

ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE TRIPHOSPHATE; ALGORITHMS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PHOSPHO-SPECIFIC; DRUG DISCOVERY; ENZYME INHIBITORS; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HYDROGEN-ION CONCENTRATION; MITOGEN-ACTIVATED PROTEIN KINASE 10; OSMOLAR CONCENTRATION; PHOSPHORYLATION; TIME FACTORS;

EID: 79951767449     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.014     Document Type: Article

References (14)

1. Pearson G., Robinson F., Gibson T.B., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
2. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell (Cambridge, Mass.) 2000, 103:239-252.
3. Manning A.M., Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discovery 2003, 2:554-565.
4. Goettert M., Graeser R., Laufer S.A. Optimization of a nonradioactive immunosorbent assay for p38alpha mitogen-activated protein kinase activity. Anal. Biochem. 2010, 406:233-234.
5. Slouka J., Bekarek V., Lycka A. Cyclization reactions of hydrazones: XIII. Cyclization reactions of some o-acylphenylhydrazones. Collect. Czech. Chem. Commun. 1982, 47:1746-1756.
6. Gallagher T.F., Seibel G.L., Kassis S., Laydon J.T., Blumenthal M.J., Lee J.C., Lee D., Boehm J.C., Fier-Thompson S.M. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg. Med. Chem. 1997, 5:49-64.
7. Peifer C., Luik S., Thuma S., Herweh Y., Laufer S. Development and optimization of a non-radioactive JNK3 assay. Comb. Chem. High Throughput Screen. 2006, 9:613-618.
8. Copeland R.A. Mechanistic consideration in high-throughput screening. Anal. Biochem. 2003, 320:1-12.
9. Scapin G., Patel S.B., Lisnock J., Becker J.W., LoGrasso P.V. The structure of JNK3 in complex with small molecule inhibitors. Structural basis for potency and selectivity. Chem. Biol. 2003, 10:705-712.
10. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971, 8:871-874.
11. R. Copeland, Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis (2000) 188-263.
12. Harper S.J., LoGrasso P. Inhibitors of the JNK signaling pathway. Drugs Future 2001, 26:957-973.
13. Lisnock J., Griffin P., Calaycay J., Frantz B., Parsons J., O'Keefe S.J., LoGrasso P. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1. Biochemistry 2000, 39:3141-3148.
14. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.